Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001415889-15-000771

Director acquired 109,920 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rubin Steven D Director 2015-03-03 Option exercise +109,920 639,920 D
Derivatives
Rubin Steven D Director 2015-03-03 Option exercise · Series B Convertible Preferred Stock −536 0 D
Loading xslF345X03/form4-03052015_020300.xml…